Potlatch (PCH) Competitors $38.20 -0.69 (-1.77%) As of 02:24 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PCH vs. OHI, CUBE, RHP, HR, EPR, SBRA, RYN, NHI, GEO, and MPWShould you be buying Potlatch stock or one of its competitors? The main competitors of Potlatch include Omega Healthcare Investors (OHI), CubeSmart (CUBE), Ryman Hospitality Properties (RHP), Healthcare Realty Trust (HR), EPR Properties (EPR), Sabra Healthcare REIT (SBRA), Rayonier (RYN), National Health Investors (NHI), Geo Group (GEO), and Medical Properties Trust (MPW). These companies are all part of the "specialized reits" industry. Potlatch vs. Its Competitors Omega Healthcare Investors CubeSmart Ryman Hospitality Properties Healthcare Realty Trust EPR Properties Sabra Healthcare REIT Rayonier National Health Investors Geo Group Medical Properties Trust Omega Healthcare Investors (NYSE:OHI) and Potlatch (NASDAQ:PCH) are both specialized reits companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, profitability, earnings and institutional ownership. Which has more risk & volatility, OHI or PCH? Omega Healthcare Investors has a beta of 0.69, indicating that its share price is 31% less volatile than the S&P 500. Comparatively, Potlatch has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500. Do institutionals & insiders have more ownership in OHI or PCH? 65.3% of Omega Healthcare Investors shares are owned by institutional investors. Comparatively, 86.1% of Potlatch shares are owned by institutional investors. 1.5% of Omega Healthcare Investors shares are owned by insiders. Comparatively, 1.0% of Potlatch shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has preferable earnings & valuation, OHI or PCH? Omega Healthcare Investors has higher earnings, but lower revenue than Potlatch. Omega Healthcare Investors is trading at a lower price-to-earnings ratio than Potlatch, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOmega Healthcare Investors$1.05B10.02$406.33M$1.6122.61Potlatch$1.06B2.83$21.88M$0.6162.62 Does the media favor OHI or PCH? In the previous week, Omega Healthcare Investors had 8 more articles in the media than Potlatch. MarketBeat recorded 10 mentions for Omega Healthcare Investors and 2 mentions for Potlatch. Omega Healthcare Investors' average media sentiment score of 1.31 beat Potlatch's score of 1.26 indicating that Omega Healthcare Investors is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Omega Healthcare Investors 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Potlatch 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend OHI or PCH? Omega Healthcare Investors presently has a consensus price target of $41.88, indicating a potential upside of 15.04%. Potlatch has a consensus price target of $48.57, indicating a potential upside of 27.15%. Given Potlatch's stronger consensus rating and higher possible upside, analysts clearly believe Potlatch is more favorable than Omega Healthcare Investors.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Omega Healthcare Investors 0 Sell rating(s) 6 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33Potlatch 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86 Is OHI or PCH more profitable? Omega Healthcare Investors has a net margin of 41.29% compared to Potlatch's net margin of 4.35%. Omega Healthcare Investors' return on equity of 9.98% beat Potlatch's return on equity.Company Net Margins Return on Equity Return on Assets Omega Healthcare Investors41.29% 9.98% 4.71% Potlatch 4.35%2.36%1.46% Is OHI or PCH a better dividend stock? Omega Healthcare Investors pays an annual dividend of $2.68 per share and has a dividend yield of 7.4%. Potlatch pays an annual dividend of $1.80 per share and has a dividend yield of 4.7%. Omega Healthcare Investors pays out 166.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Potlatch pays out 295.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Omega Healthcare Investors is clearly the better dividend stock, given its higher yield and lower payout ratio. SummaryOmega Healthcare Investors beats Potlatch on 11 of the 18 factors compared between the two stocks. Get Potlatch News Delivered to You Automatically Sign up to receive the latest news and ratings for PCH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PCH vs. The Competition Export to ExcelMetricPotlatchBLDG PRD IndustryConstruction SectorNASDAQ ExchangeMarket Cap$3.00B$9.63B$9.16B$8.90BDividend Yield4.63%2.30%2.04%4.15%P/E Ratio62.6224.8616.2519.71Price / Sales2.831.87121.10108.36Price / Cash21.0213.1914.8927.49Price / Book1.482.364.625.42Net Income$21.88M$297.37M$619.52M$248.42M7 Day Performance-2.50%-3.01%0.69%2.39%1 Month Performance-2.53%-2.03%4.33%4.79%1 Year Performance-3.02%-11.07%99.84%17.35% Potlatch Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PCHPotlatch4.6521 of 5 stars$38.20-1.8%$48.57+27.2%-1.3%$3.00B$1.06B62.621,383Positive NewsOHIOmega Healthcare Investors4.4047 of 5 stars$37.30+0.9%$41.88+12.3%+6.8%$10.79B$1.05B23.1750Positive NewsCUBECubeSmart3.7426 of 5 stars$42.93+1.3%$47.47+10.6%-6.2%$9.79B$929.08M25.403,104RHPRyman Hospitality Properties4.4337 of 5 stars$100.94+2.2%$114.43+13.4%+0.7%$6.06B$2.34B21.391,929HRHealthcare Realty Trust2.7666 of 5 stars$15.50+2.1%$16.80+8.4%-4.3%$5.45B$1.27B-14.22580EPREPR Properties3.4078 of 5 stars$59.11+1.4%$56.43-4.5%+36.9%$4.50B$698.07M36.2660SBRASabra Healthcare REIT1.0649 of 5 stars$18.59+1.9%$19.67+5.8%+18.6%$4.42B$703.23M31.5140RYNRayonier4.5397 of 5 stars$22.80+0.9%$27.75+21.7%-23.9%$3.55B$1.26B9.79420NHINational Health Investors3.3434 of 5 stars$72.34+2.2%$85.75+18.5%+4.7%$3.38B$335.18M22.9720GEOGeo Group3.0252 of 5 stars$23.42+0.6%$38.00+62.3%+66.0%$3.31B$2.42B123.2716,500MPWMedical Properties Trust3.9849 of 5 stars$4.45+0.2%$5.75+29.2%+3.4%$2.67B$995.55M-1.61120Analyst Forecast Related Companies and Tools Related Companies Omega Healthcare Investors Competitors CubeSmart Competitors Ryman Hospitality Properties Competitors Healthcare Realty Trust Competitors EPR Properties Competitors Sabra Healthcare REIT Competitors Rayonier Competitors National Health Investors Competitors Geo Group Competitors Medical Properties Trust Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PCH) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Potlatch Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Potlatch With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
